BMP2 and metabolic dysfunction-associated steatohepatitis: An algorithm based on serum BMP2 levels and clinically relevant MASLD variables can distinguish MASH (Maranon et al., 2022), indicating that abnormal BMP2 expression is linked to MASLD/MASH.